729 Followers on Owler
Fate is a California-based company that develops programmed cellular immunotherapies for treating metastatic cancer, traumatic injury, and degenerative diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
Fate is a California-based company that develops programmed cellular immunotherapies for treating metastatic cancer, traumatic injury, and degenerative diseases... Read more
Fate Therapeutics President & CEO: Bahram Valamehr

President & CEO

Bahram Valamehr

CEO Approval Rating

82/100

2007

PublicIndependent CompanyNASDAQFATE

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$13.6M
Employees
550
Funding
$366.3M
Acquisitions
1

News

Conference Presentation
Feb 14, 2025
Marketscreener
Fate Therapeutics to Present at Upcoming Investor Conferences
Leadership Change
Jan 01, 2025
Nasdaq
Bahram Valamehr is now President & CEO at Fate Therapeutics

Fate Therapeutics Competitors

1Kadmon
2Juno Therapeutics
3Chimerix
4G1 Therapeutics
5bluebird bio
6Priothera
7Atox Bio
8BioCryst
9Novartis
10Pfizer
Unlock 7 + competitors

Trending Companies